MCMCB Pro
T65.844D

T65.844DToxic effect of xylazine, undetermined, subsequent encounter

Billable / specific codeICD-10-CMPOA exempt

T65.844D is a billable, specific ICD-10-CM code for toxic effect of xylazine, undetermined, subsequent encounter. It is valid for submission on a claim.

7th character "D" — subsequent encounter

The appropriate 7th character is to be added to each code from category T65

A
initial encounter
D
subsequent encounter
S
sequela

Risk adjustment

T65.844D does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.

Medicare coverage

T65.844D is named in 1 Medicare coverage policy 1 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

  • A56612Billing and Coding: CT of the Head

Code history

What changed, and when. Derived by diffing consecutive CMS release files — which matters when you are defending a code assigned under an earlier edition.

  • addedFY2024-FY2026

    Toxic effect of xylazine, undetermined, subsequent encounter

Related codes at this level

Codes that share T65.844. If T65.844D is not quite right, the correct code is usually one of these.

Questions about T65.844D

Is T65.844D a billable ICD-10-CM code?
Yes. T65.844D is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does T65.844D sit in the tabular list?
Injury, poisoning and certain other consequences of external causes (S00-T88), in the block Toxic effects of substances chiefly nonmedicinal as to source (T51-T65).
ICD-10-CMFY2026-Apr· effective April 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release — see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.